Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

5 Cash Cows That Should Add Dividends Like Starbucks (AAPL, AMZN, CSCO, GOOG, EBAY)

By Jim Woods, Editor-in-Chief, Successful Investing, Intelligence Report, Bullseye Stock Trader
Today's announcement by coffee-giant Starbucks (SBUX) that it would pay its first dividend should be taken as a shot of double espresso heard around the world by other cash-flush companies like Apple (AAPL), Amazon.com (AMZN), Cisco (CSCO), Google (GOOG) and eBay (EBAY) still hesitant to pour out dividends.

Pharmacy Stocks Helped by Healthcare Reform (CVS, ESRX, RAD, MHS, WAG, WMT)

By Jeff Reeves
President Obama signed the health care reform bill into law Tuesday, and despite the huffing and puffing of Republicans, there's not much that can be done to change things. The legislation gives 32 million currently uninsured Americans access to medical procedures and prescription drugs -- making them prospective customers of leading prescription providers like CVS Caremark (CVS), Express Scripts (ESRX), Rite Aid (RAD), Medco Health Solutions (MHS), Walgreens (WAG) and Wal-Mart (WMT).

ETF Now Lets China Buy the S&P 500

By Robert Hsu, InvestorPlace Contributor
There was a time when the buzz around Wall Street was the creation of new ETFs that allowed U.S. investors to easily participate in the booming emerging markets. Well, in an sign of just how far the tables have turned, the buzz now on Wall Street is all about a new China-based ETF that allows Chinese investors to buy the S&P 500.

Dividend Tax Part of Paying for Healthcare

By Jim Woods, Editor-in-Chief, Successful Investing, Intelligence Report, Bullseye Stock Trader
The drama is finally over, and the votes have been cast on health care reform. Now Americans can really get a sense of what this legislation actually means for them. If you are one of society's top achievers or a dividend stock investor, chances are you feel this legislation represents a most unhealthy tax .

Stock Picks – Teva Pharmaceutical-TEVA

By Sam Collins, InvestorPlace Chief Technical Analyst
Last week's breakaway gap on huge volume suggests that Teva Pharmaceutical (TEVA) could be at the start of another major move higher.

7 Low-Risk, High-Dividend Stocks

By Richard Young, Editor, Intelligence Report
The market has surged 70% since its lows a year ago, but for many investors that doesn't mean its time to breathe easy. Securing your retirement fund or providing a steady stream of income via dividends involves a long-term strategy and a conservative approach that makes sure you protect what you've won back in the last year and maximize your performance looking forward. Top stocks include DE, ETP, GD, KMP, NOC, WR, UTX.

YUII Woes Show Growing Pains of China Stocks

By Robert Hsu, InvestorPlace Contributor
Many fortunes have been made by investors willing to buy Chinese companies whose stocks are listed on U.S. exchanges. But investing in emerging markets and in China is not without its growing pains. Case in point is the recent dust up in the shares of Chinese poultry industry firm Yuhe International (YUII).

Three Top Emerging Market Pharma Stocks

By Jeff Reeves
A recent IMS Health study predicts that by next year, drug sales in China will surpass prescriptions in France and Germany -- while Brazil will be buying more medications than the U.K. That means drugmakers in emerging markets are on the verge of a tremendous explosion in sales and profits much like the U.S. pharmaceutical industry saw at the end of the 20th century.

Shares of Chinese Insurance Broker CNinsure in the Sweet Spot

By Robert Hsu, InvestorPlace Contributor
This Chinese insurance broker is profiting from the flood of surplus cash in China, and shares of this top China stock will likely continue to surge.

Toyota Makes an Offer It Hopes Customers Can’t Refuse

By Paul Ausick
The prospects for Toyota Motors (TM) may not be quite as bleak as they were at the beginning of March. The company expects sales to grow in March, following a decline of 8.7% in February and 16% in January.

Stock Picks – Sprint Nextel Corp-S

By Sam Collins, InvestorPlace Chief Technical Analyst
Sprint Nextel Corp. (S) appears to be in an early-stage change in trend and can be accumulated here.

Stock Picks – JB Hunt Transport Services Inc-JBHT

By Sam Collins, InvestorPlace Chief Technical Analyst
The market correction caused a pullback in JB Hunt Transport Services (JBHT) after the last time we recommended the stock, but it may be time for another try.

Strong Sales of ‘Small Luxuries’ Fuel These 3 China Stocks

By Robert Hsu, InvestorPlace Contributor
By now, nearly everyone is familiar with China's emergence as an economic superpower on the strength of its exports and manufacturing. But did you know that China has now become the world's second-largest consumer of luxury goods? That means big things for consumer stocks WATG, CTRP and CAST.

Four Penny Stocks to Buy Now

By Jamie Dlugosch, InvestorPlace Writer
These four penny stocks to buy now have the chance to double in value or more. See the complete list here.

Stock Picks – Barrick Gold Corp-ABX

By Sam Collins, InvestorPlace Chief Technical Analyst
Barrick Gold Corp. (ABX) hit our trading target, but it appears there's more upside ahead for this premier mining stock.

Stock Picks – Gabelli Global Gold, Natural Resources & Income Trust-GGN

By Sam Collins, InvestorPlace Chief Technical Analyst
Gabelli Global Gold, Natural Resources & Income Trust (GGN) provides a steady dividend return, as well as a way to participate in metal mining stocks.

Potential Avandia Lawsuits Threaten GlaxoSmithCline’s (GSK) Bottom Line

By Paul Ausick
Recent reports on increased cardiac risks from using Avandia, a diabetes drug made and marketed by GlaxoSmithCline (GSK), threaten the more than $1 billion in annual sales Glaxo enjoys from the drug.

It’s Time to Dump Wal-Mart (WMT, TGT, COST, RTH)

By Jon Ogg
Wal-Mart stock is dead money, and for WMT stock to rise, a significant dividend hike is necessary.

Taiwanese Stocks Will Continue to Perform in 2010

By Robert Hsu, InvestorPlace Contributor
There are three main reasons why Taiwanese stocks will continue to be a good bet this year. Get details here, plus the best way to profit from this trend.
Load More Articles